{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:14:52Z","timestamp":1790147692681,"version":"4.0.1"},"reference-count":0,"publisher":"BioExcel","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DIC"],"DOI":"10.7573\/dic.212518","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T07:47:04Z","timestamp":1524469624000},"page":"1-10","source":"Crossref","is-referenced-by-count":46,"title":["Cardiac myosin activators for heart failure therapy: focus on omecamtiv mecarbil"],"prefix":"10.7573","volume":"7","author":[{"given":"Edgardo","family":"Kaplinsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Mallarkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10047","published-online":{"date-parts":[[2018,4,23]]},"container-title":["Drugs in Context"],"original-title":[],"link":[{"URL":"https:\/\/www.drugsincontext.com\/wp-content\/uploads\/2018\/04\/dic.212518.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T20:02:09Z","timestamp":1578686529000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.drugsincontext.com\/cardiac-myosin-activators-for-heart-failure-therapy-focus-on-omecamtiv-mecarbil"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,23]]},"references-count":0,"URL":"https:\/\/doi.org\/10.7573\/dic.212518","relation":{},"ISSN":["1740-4398"],"issn-type":[{"value":"1740-4398","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,23]]}}}